FLDM News 37.10 Fluidigm Corp (FLDM)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fluidigm Corp (FLDM) 37.10 $FLDM

Nasdaq stocks posting largest percentage increases
AP - Mon Apr 14, 1:08PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at 1 p.m.:

Why Fluidigm (FLDM) Stock Is Up Today
at The Street - Mon Apr 14, 11:02AM CDT
Fluidigm (FLDM) shares are up in trading on Monday following an analysts upgrade.

Fluidigm (FLDM) is now in Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 7:54AM CDT
Fluidigm (FLDM) is now in Oversold Territory

Analyst Bullish On Medical Research, Equipment Stocks
at Investor's Business Daily - Tue Apr 08, 12:33PM CDT
A new analyst report from Cowen & Co. offers an upbeat assessment of medical research and equipment stocks ahead of first-quarter earnings, thanks to improving end markets. In his report on the Life Sciences and Diagnostic Tools sectors on Tuesday,...

Insider Trading Alert - BHI, FLDM And CTAS Traded By Insiders
at The Street - Fri Apr 04, 9:30AM CDT
Stocks with insider trader activity include BHI, FLDM and CTAS

Single Cell Omics Trends - Global Market Overivew 2014
M2 - Tue Apr 01, 10:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j5vvw9/single_cell_omics) has announced the addition of the "Single Cell Omics Trends" report to their offering. Single Cell Omics, a cutting edge technology, mainly integrates advanced technology with biology for a variety of single cell applications. The technology helps to study single cells at a much deeper level which allows identifying important genomic variations. The report analyzes and presents an overview of Single Cell Omics market worldwide. The report also offers global market estimates and projections for Single Cell Omics technology and products in US dollars for years 2012 through 2017. Key geographic market quantitatively analysed include the Unites States, Europe, Asia Pacific, and Japan. Supported with 6 market data tables, the report provides a review of market trends, application areas, growth opportunities, and challenges. The data table highlights global Single Cell Omics market by applications, technology, product, region, and field of study. Key Topics Covered: 1. SINGLE CELL OMICS - A MARKET OVERVIEW - Single Cell Analysis - A Revolutionary Technology Changing Market Dynamics - Single Cell Genomics - An Introduction - Biological Research Shifting from Tissue/Organ Level Approach to a Single Cell - Single Cell Analysis - Role of Omics - Single-Cell Isolation Techniques - Single Cell Omics - Applications - Single Cell Omics - Major Application Areas - SCA Devices - Technological Improvements - Single Cell Omics - Growth Opportunities Vs. Challenges - Global Single Cell Omics Market to Register Mammoth Growth Rate - Single Cell Omics Market by Technology - Single Cell Omics Market by Field of Study - Single Cell Omics Market by Applications - Picodroplet Single Cell Analysis Technology Witnesses Significant Surge - Major Players in the Single Cell Isolation Market - Major Players in the Single Cell Sample Preparation Market - Major Players in the Single Cell Genomic Analysis Market 2. RECENT INDUSTRY ACTIVITY - Genome Institute of Singapore and Fluidigm Open GIS-Fluidigm - Single-Cell Omics Center in Singapore - Sphere Fluidics Develops New Technologies for Single Cell Analysis 3. MARKET PARTICIPANTS - BD Biosciences - BioNano Genomics, Inc. - DVS Sciences, Inc. - Fluidigm Corporation - Fluxion Biosciences, Inc. - Life Technologies Corporation - Molecular Machines & Industries (MMI) - NanoString Technologies, Inc. - NuGEN Technologies, Inc. - Qiagen NV - Roche Applied Science - Silicon Biosystems - Sphere Fluidics Ltd. - Tataa Biocenter AB - Thermo Fisher, HCA Company 4. APPENDIX For more information visit http://www.researchandmarkets.com/research/j5...cell_omics

Global Biochips Market 2012-2016: Major Challenge for Market is High Cost Incurred in the Implementation of Biochips
M2 - Thu Mar 20, 11:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bcvpcl/global_biochips) has announced the addition of the "Global Biochips Market 2012-2016" report to their offering. The analysts forecast the Global Biochips market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. Key vendors dominating this space include Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd. and Agilent Technologies Inc. Other vendors mentioned in the report are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc. Commenting on the report, an analyst from the Hardware team said: ''Over the years, numerous drug manufacturers have been outsourcing their drug development processes to contract research organizations. Outsourcing activities reduce manufacturing and distribution costs, ensure quality of service, and reduce lead time. They also help the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. These contract research organizations employ the latest technologies and sophisticated instruments, and thus increased outsourcing to such organizations is a positive trend for the Global Biochips market.'' According to the report, one of the major drivers is the growing need for high speed diagnosis from patients and doctors. Biochips are specially designed with advanced technology that makes them ultra-efficient, therefore, enhancing their operating speed to a great extent. For more information visit http://www.researchandmarkets.com/research/bc...l_biochips About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Concise Analysis of the International qPCR and dPCR Instrumentation Market
M2 - Tue Mar 18, 4:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/f2m2mm/qpcr_and_dpcr) has announced the addition of the "Concise Analysis of the International qPCR and dPCR Instrumentation Market" report to their offering. This report analyzes the worldwide markets for qPCR and dPCR Instrumentation in US$ Million. The Global market is further analyzed by the following Product Segments and End-Use Markets: Product Segments - qPCR (quantitative Polymerase Chain Reaction), and dPCR (digital Polymerase Chain Reaction); End-Use markets - Educational/Research, Testing Laboratories, and Pharma. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2018. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 49 companies including many key and niche players such as: - Agilent Technologies - Biofire Diagnostics, Inc. - Bio-Rad Laboratories, Inc. - Cepheid - Eppendorf AG - Exiqon A/S - F. Hoffmann-La Roche Ltd. - Fluidigm Corporation - Illumina, Inc. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW 2. MAJOR TRENDS & ISSUES 3. COMPETITION 4. END-USE MARKET ANALYSIS 5. PRODUCT OVERVIEW 6. INSIGHT INTO GLOBAL SPENDING ON LIFE SCIENCES RESEARCH 7. PRODUCT INNOVATIONS/ INTRODUCTIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT GLOBAL PLAYERS 10. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. MIDDLE EAST & AFRICA 7. LATIN AMERICA IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 49 (including Divisions/Subsidiaries - 51) - The United States (29) - Canada (1) - Japan (1) - Europe (19) - Germany (7) - The United Kingdom (2) - Spain (1) - Rest of Europe (9) - Asia-Pacific (Excluding Japan) (1) For more information visit http://www.researchandmarkets.com/research/f2...r_and_dpcr

Microfluidics Market Report 2013-2018: Materials, Pharmaceuticals, Drug Delivery Devices & IVD
M2 - Fri Mar 14, 9:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7zswzc/microfluidics Normal 0 false false false EN-IE X-NONE X-NONE ) has announced the addition of the "Microfluidics Market Report 2013-2018: Materials, Pharmaceuticals, Drug Delivery Devices & IVD" report to their offering. The microfluidics market is segmented based on materials, products, and applications. This report studies market trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices. The market is expected to grow at a strong CAGR during the study period. This is due to factors such as the rising demand for POC devices, quick return on investments provided by microfluidics devices which helps in cost reductions, and miniaturization of microfluidic chips. However, factors such as difficulty in incorporation of emerging microfluidic technologies into existing workflows and complex and time consuming regulatory standards are hampering the growth of this market. Microfluidics is defined as the science of designing, fabricating, and formulating products and processes that deal with low volumes of fluids in the range of nanoliters or picoliters. The technology evolved from MEMS (Micro Electro Mechanical Systems) devices and can replicate all the functions of its counterparts in various healthcare applications such as, drug delivery, Point-of-Care (POC), and clinical diagnostics. This study covers the materials, industries, and applications revenue markets for the global market. The global revenue generated from various microfluidics products used in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices is considered to estimate the market size. Material - Polymer-based Microfluidics - Glass-based Microfluidics - Silicon-based Microfluidics - Other Material-based Microfluidics Industry Pharmaceuticals - -- Microfluidic Chips for Laboratory Analytics - --- Toxicity Screening - --- Proteomics Analysis - --- Gene Sequencing - --- Capillary Electrophoresis - -- Accurate Dispensing Devices - -- Microreactors for Drug Synthesis - -- In-Vitro Diagnostics - --- Clinical Diagnostics - --- Point--- of--- Care Testing - --- Environmental Testing - --- Industrial Testing - --- Agro Food Testing - -- Drug Delivery Devices - --- Inhaler Nozzles - --- Micro Needles - --- Micro Pumps Application - Drug Delivery - Industrial and Environmental - Analytical Devices - Pharmaceutical and Life Sciences Research - Point-of-Care Diagnostics - Clinical and Veterinary Diagnostics Companies Mentioned - Abbott Laboratories, Inc. - Agilent Technologies - Bartels Mikrotechnik Gmbh - Becton, Dickinson And Company 1 Becton Drive - Bio-Rad Laboratories, Inc. - Biofluidix Gmbh - Cepheid, Inc. - Danaher Corporation - Fluidigm Corporation - Johnson & Johnson - Life Technologies Corporation - Microfluidic Chipshop Gmbh - Perkinelmer, Inc. - Raindance Technologies - Roche Diagnostics Limited - Scienion Ag - Siemens Healthcare For more information visit http://www.researchandmarkets.com/research/7z...rofluidics Normal 0 false false false EN-IE X-NONE X-NONE

Fluidigm to Present at the Cowen and Company 34th Annual Health Care Conference
Business Wire - Wed Feb 26, 8:01AM CST
Fluidigm Corporation (NASDAQ:FLDM) today announced that it will present at the Cowen and Company 34th Annual Health Care Conference in Boston, on Tuesday, March 4, 2014, at 8:40 a.m. (EST).

Prenatal Testing Market in the US 2014-2018: Perkinelmer Inc. Expands its Screening Test Offerings, Introducing the First Early Onset Preeclampsia Screening Test in the US in 2013
M2 - Tue Feb 25, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/x2lvh8/prenatal_testing) has announced the addition of the "Prenatal Testing Market in the US 2014-2018" report to their offering. The analysts forecast the Prenatal Testing market in the US to grow at a CAGR of 5.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of fetal health-related abnormalities. The Prenatal Testing market in the US has also been witnessing the significant increase in the launch of new tests. However, the falling fertility rates in the US could pose a challenge to the growth of this market. Key vendors dominating this space are PerkinElmer Inc., Quest Diagnostics Inc., Sequenom Inc., and Verinata Health Inc. Other vendors mentioned in the report are ANGLE plc, Ariosa Diagnostics Inc., BGI Health, CellScape Corp., Fluidigm Corp., Ikonisys Inc., Kellbenx Inc., Natera Inc., Ravgen Inc., and Trovagene Inc. Commenting on the report, an analyst from the team said: The Prenatal Testing market in the US is experiencing a significant increase in the number of new tests being launched in the market. For instance, Sequenom launched Laboratoire Cerba's non-invasive prenatal test in San Diego, California, and Saint-Ouen-L'Aumone, France, in December 2013 and enhanced the sequencing series for its MaterniT21 PLUS laboratory-developed test in October 2013. Moreover, PerkinElmer Inc. expanded its prenatal screening test offerings, introducing the first early onset preeclampsia screening test in the US in August 2013. This trend will have a positive impact on the growth of the market. According to the report, one of the major factors driving the market is the increase in the incidence of fetal abnormalities such as Down syndrome, Edwards syndrome, neural tube defects, and genetic defects and disorders such as sickle cell anemia, thalassemia, spina bifida, Tay Sachs disease, cystic fibrosis, muscular dystrophy, cleft palate and fragile X syndrome. For more information visit http://www.researchandmarkets.com/research/x2...al_testing About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Fluidigm Completes Acquisition of DVS Sciences
Business Wire - Thu Feb 13, 3:30PM CST
Fluidigm Corp. (NASDAQ: FLDM) today announced it has completed its acquisition of DVS Sciences, Inc. With the closing of the acquisition, Fluidigm adds a high-parameter single-cell protein analysis platform to its industry-leading single-cell genomics platforms to create a comprehensive portfolio of advanced technologies serving the rapidly growing single-cell genomics and proteomics markets.

Research and Markets: Myo-inositol (CAS 87-89-8) Market Research Report 2013
Business Wire - Wed Feb 12, 6:02AM CST
Research and Markets (http://www.researchandmarkets.com/research/zh7psm/myoinositol_cas) has announced the addition of the "Myo-inositol (CAS 87-89-8) Market Research Report 2013" report to their offering.

Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 7:30AM CST
The shares of Fluidigm Corporation fell over 6% on the day.This reverses the most recent uptrend for the company, as the stock is now up almost 8% since Jan 29.This scientific instruments company has seen a flat track record when it comes to current year estimate revisions.

Fluidigm Reports Strong Revenue for Q4 and the Full Year 2013
Business Wire - Thu Feb 06, 3:00PM CST
Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2013.

Insider Trading Alert - CMA, FLDM, CNQR, MFRM And AWAY Traded By Insiders
at The Street - Thu Feb 06, 9:30AM CST
Stocks with insider trader activity include CMA, FLDM, CNQR, MFRM and AWAY

Fluidigm to Announce Q4/Full Year 2013 Financial Results and Host Conference Call for Investors
Business Wire - Fri Jan 31, 5:30PM CST
Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and 2013 full year financial results on February 6, 2014, after close of market.

Fluidigm Announces Pricing of $175 Million Convertible Senior Notes Offering
Business Wire - Thu Jan 30, 7:00AM CST
Fluidigm Corporation (NASDAQ:FLDM), a supplier of microfluidic systems for growth markets in the life science and agricultural biotechnology industries, today announced the pricing of its offering of $175 million aggregate principal amount of its 2.75% convertible senior notes due 2034 (the "notes" in an underwritten public offering. Fluidigm has granted the underwriter of the notes a 30-day option to purchase up to an additional $26.25 million aggregate principal amount of the notes to cover over-allotments, if any. The offering is expected to close on or around February 4, 2014, subject to satisfaction of customary closing conditions.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 73

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Pompeii Fountain Tests the Value of Concrete Durability

Updated Category News Views 96

Nearly 2,000 nozzles throwing water around a public attraction is a fine way to expose every weak seam in a concrete job. The Fontana Danzante in Pompei, completed in late 2025, is not some quiet decorative basin. It is described as Italy's largest fountain, a nearly 200-meter installation near the Pompeii Archaeological Park that continuously stores, circulates and...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 51

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading
Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 124

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
Atalanta Takes Formal Verification Into Critical Systems

Updated Category News Views 370

A week of bewildering infrastructure failures is a nasty time to discover nobody can explain the machinery. That was the backdrop for Atalanta CEO and co-founder Anjana Rajan at the National Academies of Sciences, Engineering, and Medicine's Cyber Resilience Forum, which concluded November 20 after two days in Washington. Her central point deserves more attention than the...

Continue Reading
Morrison Tests Abu Dhabi as Its Next Capital Hub

Updated Category News Views 97

Abu Dhabi keeps collecting infrastructure managers the way a strong port collects ships: because the money, the policy ambition, and the projects are all converging there. Morrison’s decision to establish an office in ADGM is not some chest-thumping headline about instant deal flow. It is a practical move by a firm with nearly four decades behind it and more than US$35...

Continue Reading
OU's $44.3M Rural Care Plan Targets Oklahoma Care Gaps

Updated Category News Views 70

A Long Drive Is a Brutal Barrier to Care Seventy-five of Oklahoma's 77 counties sit in health professional shortage territory, a figure that ought to stop people cold. It means at least 3,500 patients per provider in those counties. That is not some abstract planning headache. It is the pregnant patient delaying a specialist visit, the family weighing an ambulance ride,...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 60

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 23

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
ASU's International Enrollment Lead Carries Real Weight

Updated Category News Views 90

Twenty thousand nine hundred twenty-six international students is not a campus footnote; it is a serious operating force moving through Arizona State University and the state around it. ASU has held the No. 1 spot among U.S. public universities hosting international students for six straight years, and the 2026 Open Doors report puts it No. 2 across public and private...

Continue Reading

Top 5 Most Recently Viewed Articles

Sarepta Therapeutics Faces Class Action Lawsuit: Key Facts

Updated Category News Views 222

Understanding the Recent Class Action Against Sarepta Therapeutics The law firm of Kessler Topaz Meltzer & Check, LLP has announced an important development for investors in Sarepta Therapeutics, Inc. (NASDAQ: SRPT). A securities class action lawsuit has been filed in the Southern District of New York, which impacts those who purchased or otherwise acquired Sarepta's...

Continue Reading
Honoring Dr. Marvin Boomer Jr. and Advocating for Justice

Updated Category News Views 459

A Community's Tribute to Dr. Marvin Boomer Jr. Today we unite not just in sorrow but in a fierce dedication to remember Dr. Marvin Boomer Jr. His life, marked by brilliance and inspiration, serves as a beacon for many. As we reflect on his contributions, we recognize the larger struggles that affect our community. The Impact of Dr. Boomer's Legacy Dr. Marvin Boomer Jr....

Continue Reading
Key Economic Events and Insights from Kashkari's Speech

Updated Category News Views 154

Anticipating Economic Insights from Kashkari's Address As financial markets gear up for another significant day, numerous crucial economic events are set to occur. Traders are especially keen on the insights that FOMC Member Neel Kashkari may share regarding the Federal Reserve's stance on monetary policy. His speech is expected to potentially guide market reactions and...

Continue Reading
Discover Compelling Dividend Stocks for Investors

Updated Category News Views 126

Exploring Attractive Dividend Stocks The stock market has recently reached several new all-time highs, influenced by a variety of economic factors. While this upward trend has benefited many stocks, it has also limited the number of valuable bargains for investors. However, some companies still stand out as exceptional investment opportunities. Currently, three notable...

Continue Reading
New Housing Initiatives in Canada to Combat Housing Shortage

Updated Category News Views 264

Boosting Housing Availability Across Canada The governments are coming together to tackle the pressing issue of affordable housing in Canada. Their concerted efforts have culminated in a substantial funding package aimed at enhancing the housing landscape. Recently, over $44 million has been dedicated towards constructing more than 280 new homes, further expanding the...

Continue Reading